Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis

  • Richard N Greenberg,
  • Maria Yadira Hurley,
  • Dinh V. Dinh,
  • Serena Mraz,
  • Javier Gomez Vera,
  • Dorothea von Bredow,
  • Alfred von Krempelhuber,
  • Siegfried Roesch,
  • Garth Virgin,
  • Nathaly Arndtz-Wiedemann,
  • Thomas Peter Meyer,
  • Darja Schmidt,
  • Richard Nichols,
  • Philip Young,
  • Paul Chaplin
  • Article
  • Metrics
  • Comments
  • Media Coverage

The second author’s name is spelled incorrectly. The correct name is: Maria Yadira Hurley. The correct citation is: Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, von Bredow D, et al. (2015) A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis. PLoS ONE 10(10): e0138348. doi:10.1371/journal.pone.0138348

Reference

  1. 1. Greenberg RN, Hurley Y, Dinh DV, Mraz S, Vera JG, von Bredow D, et al. (2015) A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis. PLoS ONE 10(10): e0138348. pmid:26439129

Citation: Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, von Bredow D, et al. (2015) Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis. PLoS ONE 10(11): e0142802. https://doi.org/10.1371/journal.pone.0142802

Published: November 10, 2015

Copyright: © 2015 Greenberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited